On 2025-05-08, Rallybio Corporation (RLYB) announced earnings per share of $-0.21 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.21.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.21 | $-0.21 |
| 2025-03-13 | 2024-12-31 | $-0.27 | $-0.25 |
| 2024-11-07 | 2024-09-30 | $-0.36 | $-0.26 |
| 2024-08-08 | 2024-06-30 | $-0.42 | $-0.37 |
| 2024-05-09 | 2024-03-31 | $-0.50 | $-0.47 |
| 2024-03-12 | 2023-12-31 | $-0.44 | $-0.50 |
| 2023-11-09 | 2023-09-30 | $-0.51 | $-0.45 |
| 2023-08-08 | 2023-06-30 | $-0.48 | $-0.46 |
| 2023-05-09 | 2023-03-31 | $-0.50 | $-0.43 |
| 2023-03-06 | 2022-12-31 | $-0.63 | $-0.46 |
| 2022-11-07 | 2022-09-30 | $-0.54 | $-0.60 |
| 2022-08-08 | 2022-06-30 | $-0.61 | $-0.57 |
| 2022-05-10 | 2022-03-31 | $-0.48 | $-0.48 |
| 2022-03-15 | 2021-12-31 | -- | $-0.42 |
| 2021-11-10 | 2021-09-30 | $-0.89 | $-0.37 |
| 2021-09-09 | 2021-06-30 | $-4.31 | $-2.80 |